Paper
0
Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1)
Authors
Yun Goh,Siew‐Wai Fong
Pei Hor,Chiew Loh,Matthew Tay,Cheng-I Wang,Siti Salleh,Eve Ngoh,Raphael Lee,Xuan Poh,I Lee,Po Chia,Pribivac Group,Sébastian Maurer-Stroh,Yee‐Sin Leo,David Lye,Barnaby Young,Lisa Ng,Laurent Rénia,Sebastian Maurer‐Stroh
+18 authors
,Yee LeoPublished
Sep 1, 2024
Show more
Save
Tip0
TipSave
Abstract
The emergence of new SARS-CoV-2 variants has led to the development of Omicron-targeting bivalent mRNA vaccines. It is crucial to understand how bivalent vaccines may improve antibody responses against new variants.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.